Barclays Maintains a Sell Rating on Patterson Companies (PDCO)
Barclays analyst Steven Valiquette maintained a Sell rating on Patterson Companies (PDCO) yesterday and set a price target of $18.00. The company’s shares closed last Monday at $23.10.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 5.5% and a 57.4% success rate. Valiquette covers the Services sector, focusing on stocks such as Molina Healthcare, Diplomat Pharmacy, and Tenet Healthcare.
Patterson Companies has an analyst consensus of Moderate Sell, with a price target consensus of $18.00.
See today’s analyst top recommended stocks >>
Based on Patterson Companies’ latest earnings release for the quarter ending October 31, the company reported a quarterly GAAP net loss of $33.13 million. In comparison, last year the company had a net profit of $28.87 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Patterson Cos., Inc. engages in dental and animal health supplies. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions an value-added services to dentists and dental laboratories.